In a report released on February 19, Mike Kratky from Leerink Partners reiterated a Buy rating on Penumbra (PEN – Research Report), with a ...

Skilled nursing deals are plentiful, and private equity has a large role to play in their abundance, according to leaders at ...

Wall Street is still awaiting regulatory approval for the first full-blown private-asset ETFs, but for now opportunistic ...

PE Hub expects to see more footwear investment deals in the coming months, as the market drivers that led to these deals are ...

PE, school sports and physical activity (PESSPA) are critical tools in fostering healthier, happier and more resilient children and young people, a new study from University of Manchester experts in ...

Discover Zealand Pharma's Q4 2024 earning highlights, key obesity pipeline advancements, and future plans for petrelintide and dapiglutide.

Investors might want to bet on Penumbra (PEN), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...

Q4 2024 Earnings Call Transcript February 18, 2025 Penumbra, Inc. beats earnings expectations. Reported EPS is $0.97, ...

Q4 2024 Earnings Conference Call February 18, 2025 4:30 PM ETCompany ParticipantsCecilia Furlong - Director of ...

Both physical therapists and chiropractors can help you move better and feel better after an injury by using non-invasive methods to help treat pain. However, their services may differ in the scope of ...